Disappearance of Seasonal Respiratory Viruses in Children Under Two Years Old During COVID-19 Pandemic: A Monocentric Retrospective Study in Milan, Italy

Background: The containment measures adopted during COVID-19 pandemic have influenced the epidemiology of other respiratory viruses.

Aim: We analyzed the modification of the incidence and etiology of lower respiratory tract infections (LRTIs) in young children during COVID-19 pandemic.

Methods: Case series of all children under 2 years old hospitalized at a tertiary care Hospital in the Center of Milan, Italy diagnosed with LRTIs in three consecutive winter seasons (from the 1st of November to the last day of February in 2018/2019, 2019/2020 and 2020/2021). We compared the number of hospitalizations and viral detections in the 2020/2021 with the average of 2018/2019 and 2019/2020 (pre-COVID-19) using the Poisson distribution.

Results: we enrolled 178 patients (66 from 2018/2019, 96 from 2019/2020, 16 from 2020/2021) 94 males (53%) and 84 females (47%), with a median (IQR) age of 5 (2–13) months. The number of hospitalizations during the 2020/2021 season was 80% lower than the average of the pre-COVID-19 seasons (16 vs. 81, p<0.001). Overall, 171 (96%) patient's nasopharyngeal aspirate (NPA) detected at least one virus (110, 64%, single-detection, 61, 36%, co-detections). In 2020/2021 we observed the disappearance of Respiratory Syncytial virus (0 vs. 54, p < 0.001), Influenza virus (0 vs. 6.5, p = 0.002), Metapneumovirus (0 vs. 8, p < 0.001), Parainfluenza viruses (0 vs. 3.5, p = 0.03) and a significant reduction of Adenovirus (2 vs. 7, p = 0.03), Bocavirus (2 vs. 7.5, p = 0.02) and Enterovirus (1 vs. 5, p = 0.04). No significant difference was found for Rhinoviruses (14 cases vs. 17, p = 0.2), other Coronaviruses (0 vs. 2, p = 0.1), and Cytomegalovirus (1 vs. 1, p = 0.7).

Conclusions: We observed a striking reduction in hospitalizations due to LRTIs and a modification of the etiology, with enveloped viruses mainly affected.

Introduction

COVID-19 pandemic is the major medical emergency of the 21st century for both healthcare professionals and the general population. For a disease lacking specific therapy, prevention is mandatory to reduce its morbidity and lethality rate. Vaccination is a very promising tool for future prevention (1–5). Before the achievement of a wide spread vaccination coverage, non-pharmacological interventions (NPI) have been and continue to be widely recommended by most Governments to contain the spread of SARS-CoV-2. Using facial masks, social distancing, adequate hand hygiene, surface disinfection and ventilation of indoor spaces are recommended by National Governments and extensively used by the general population (6). Despite the severe containment measures adopted, Italy has reported and continue to report a high number of infections (on 15th May 2021, 4,126,163 cumulative cases and 122,228 deaths) (7). Among the various NPI, many countries closed schools and kindergartens during lockdowns, resulting in substantial reduction in social interactions. To-date, the effect of school closure is seemingly associated with beneficial effects on overall mortality per week, (8) and has probably different effects depending on the age of children attending schools (9, 10). There is a general consensus on NPI effectiveness in containing SARS-CoV-2, even if before the COVID-19 pandemic evidence supporting isolate NPIs was low (11). Apart from those related to SARS-CoV-2, many studies report a reduction of hospitalization due to lower respiratory tract infections (LRTIs) caused by seasonal respiratory viruses since the first lockdown in March 2020 (12–21). This trend is confirmed by weekly reports of epidemic Influenza virus infection, which show a striking reduction of cases of influenza when compared to previous years (22). Since youngest children are not required to wear personal protective equipment in many Countries, and management of personal hygiene is often not easy, a reduction of respiratory infections may have an environmental explanation.

To our knowledge no study to date compared clinical and microbiologic features of LRTIs, a leading cause of morbidity and mortality in pediatric patients (12, 23, 24) in younger children before and after the documented spread of SARS-CoV-2.

Materials and Methods

Design, Setting, and Patients

We performed a retrospective observational study at a tertiary care Hospital (IRCCS Fondazione Cà Granda Ospedale Maggiore Policlinico) of Milan, Northern Italy, in three consecutive winter seasons (2018/2019, 2019/2020 and 2020/2021) from the 1st of November to the last day of February. All hospitalized children under 2 years old diagnosed with LRTI, intended as bronchiolitis or community acquired pneumonia, who underwent a nasopharyngeal aspirate (NPA) for detection of viruses were included. Diagnosis of LRTI was clinically suspected at the admission and confirmed by an expert physician as discharge diagnosis. The NPA for viruses detection tested nucleic acid of respiratory viruses by a multiplex polymerase chain reaction (Allplex Respiratory panel Kit) targeting Influenza virus A and B, Respiratory Syncytial Virus (RSV) (strains A and B were not detectable by this method), Metapneumovirus, Human Bocavirus, Rhinovirus, Coronavirus (subtypes OC43, 229E, and NL23 were not distinguishable by this method), Parainfluenzavirus (strains 1, 2, 3, and 4 were categorized by this method), Adenovirus, Enterovirus (this method can't differentiate Coxsackie from Echoviruses and Polioviruses). Cytomegalovirus was tested only when clinically suspected. In the 2020/2021 season two NPAs for detection of SARS-CoV-2 were performed for each patient (Allplex SARS-CoV-2 Kit). We retrospectively collected data on sex, age in months, selected common risk factors for respiratory infections, treatment and hospitalization days. The institutional ethics board of IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan, approved this study which included a waiver of informed consent because of the retrospective nature of the investigation.

Statistical Analysis

The proportion of positive NPAs from 1st November to the last day of February were calculated for each winter season in the study (2018/2019; 2019/2020; 2020/2021). The incidence of hospitalization for LRTIs for single viruses was estimated by the mean numbers of events in 2018/2019 and 2019/2020 winter seasons, called pre-COVID-19 seasons. This average was compared with the number of events in 2020/2021 winter season (COVID-19 season group) using the univariate lower tail test of Poisson distribution. Data from pre-COVID-19 seasons and 2020/2021 season were compared. Descriptive statistics were performed: continuous data are presented as median and interquartile range, and categorical data as numbers and percentages. The χ2 test or Fisher's exact test were used for categorical variables, the Mann-Whitney U-test for continuous ones. Statistical significance was considered as a p-value under 0.05. Statistical analysis was performed using R software (version 3.6.0 for Windows).

Results

During the observational period, 183 children under 2 years of age with a diagnosis of LRTI were hospitalized. Five patients were excluded, three because they did not undergo a NPA for virus detection, two because of missing data. Four of the excluded patients were admitted during the 2019/2020 winter season, the other one during the 2020/2021 winter season. Thus, a total of 178 patients were enrolled in our study: 66 patients were enrolled in winter season 2018/2019 (54 from the Pediatric Unit and 12 from the Pediatric Intensive Care Unit, respectively), 96 were enrolled in winter season 2019/2020 (78 from the Pediatric Unit and 18 from the Pediatric Intensive Care Unit, respectively), 16 patients were enrolled during winter season 2020/2021, all from the Pediatric Unit. Compared with the average number of hospitalized children in the pre-COVID-19 seasons (81 cases), during 2020/2021 the reduction was 80%. The reduction was statistically significant (cumulative Poisson probability, p < 0.00001).

Demographics, Risk Factors and Comorbidities

Demographic characteristics and risk factors are summarized in Table 1. Our cohort included 94 males (52,8%) and 84 females (47,2%), with a median age of 5 months (IQR 2–13). Thirty-seven patients (20,8%) had a diagnosis of one or more concurring chronic diseases, cardiovascular diseases (14), gastrointestinal disease (9), neurologic disease (9), pulmonary disease (8), and hepatic disease (2), respectively; 16 had multi-organ disease. As concerns other risk factors traditionally linked with LRTIs in infants, 43 patients (24,1%) were born prematurely (26, > 34 weeks gestational age, GA, and 17, < 34 weeks GE), 65 patients (36,5%) were exclusively fed with formula milk from birth, 42 patients (23,6%) were exposed to second-hand smoke. There were some differences between the two groups: hospitalized children during 2020/2021 were older (median age 11.8 months IQR 3–16 vs. 4.3 months IQR 2–10 months; p = 0.04) and they had more chronic diseases (44 vs. 18%, p = 0.02).

TABLE 1

Table 1. Viral detections, demographic characteristic and risk factors in pre-COVID-19 seasons and 2020/2021.

Respiratory Virus Circulation

Overall, 171 patients (96%) had a positive NPA: 110 of them were positive for a single virus, 61 for co-detections, for a total of 249 viruses detected. The proportion of negative, positive and co-detections did not significantly differ between pre-COVID-19 seasons and COVID-19 season (Table 1). The prevalence of single viruses by year is summarized in Table 2. Figure 1 shows the cumulative detection of viruses by year. Table 3 compares the prevalence of single viruses in the COVID-19 season as compared to the average of pre-COVID-19 ones. There was a significant reduction of RSV (0 cases vs. 54 average cases, p < 0.00001), influenza A and B (0 cases vs. 6.5 average cases, p = 0.0015), Adenovirus (2 cases vs. 7 average cases, p = 0.03), Bocavirus (2 cases vs. 7.5 average cases, p = 0.02), Enterovirus (1 case vs. 5 average cases, p = 0.04), Metapneumovirus (0 cases vs. 8 average cases, p = 0.0003), Parainfluenza viruses (0 cases vs. 3.5 average cases, p = 0.03) from pre-COVID-19 seasons and 2020/2021 season. No significant difference was found for Rhinoviruses (14 cases vs. 17 average cases, p = 0.28), other Coronaviruses (0 cases vs. 2 average cases, p = 0.13) and Cytomegalovirus (1 case vs. 1 case, p = 0.735). During COVID-19 season two of 16 patients tested positive for SARS-CoV-2: both of them had viral co-infections (one patient had a NPA positive for Bocavirus, the other one for Rhinovirus).

TABLE 2

Table 2. Viral detections by years.

FIGURE 1

Figure 1. Cumulative respiratory viruses detections by year and viral species.

TABLE 3

Table 3. Average number of viral detections in pre-COVID-19 seasons and viral detections in 2020/2021 season for viral type.

Therapies and Outcomes

In the pre-COVID-19 seasons 83% of the patients needed oxygen therapy compared to 43% in the 2020/2021 season (p = 0.05). The time of hospitalization was shorter for children during the COVID-19 season than those in the pre-COVID-19 seasons (median 4 days IQR 4–6 vs. median 6 days IQR 5–8; p = 0.006). Therapies and outcome measures are summarized in Table 4.

TABLE 4

Table 4. Therapies and outcomes in pre-Covid seasons and 2020/2021 season.

Discussion

Our study suggests that preventing measures against SARS-CoV-2 had a significant impact on the epidemiology of acute respiratory infections in infancy, with consequences affecting particularly the incidence and the etiology of viral respiratory infections. According to our data, there was a dramatic drop in the number of hospitalizations for LRTIs in children under 2 years old when we compared the 2020/2021 winter season with the two seasons prior to the emergence of SARS-CoV-2 in Italy, with an 80% reduction. The reasons for these findings are likely multifactorial. Although the effectiveness of NPIs in preventing the circulation of respiratory viruses is still widely debated, published evidence suggests that wearing facial masks is effective if combined with other NPIs, such as social distancing and avoidance of overcrowding (25), and that hand hygiene reduces respiratory illnesses (11). Among the most important risk factors for respiratory infections in children, childcare attendance is known to play an important role (26). Hence, the decision of the Italian Government to close day-care centers and schools has limited close contact between children and with teachers, possibly contributing to limit the spread of infections. Moreover, the use of face masks, although not recommended for children younger than 2 years (27), could have reduced infections in household members, lowering the viral shedding in exhaled breath (28). Some authors postulated that the effectiveness of these interventions in reducing viral transmission varies depending on the characteristics of the virus, especially the duration of pre-symptomatic shedding and incubation period (9). If the transmission occurs mainly before the onset of symptoms, NPIs targeting symptomatic patients could have a limited efficacy in reducing the viral spread.

We also report a significant modification in the viral etiology of LRTIs. During the COVID-19 season a total or substantial decline was detected in the prevalence of RSV, Influenza A and B, Metapneumovirus and Parainfluenza viruses, compared to the previous years. We also observed a strong reduction in prevalence of Adenovirus, Bocavirus and Enterovirus, although less impressive than the aforementioned. In contrast, no differences were seen for Rhinovirus, which was the most common virus identified during the COVID-19 season (up to 87% of the positive NPAs). Interestingly, our findings showed that the most common seasonal viruses (e.g., RSV, Influenza, Parainfluenza and Metapneumoviruses) were strongly curtailed in COVID-19 season. Similar results have been described by recent studies worldwide (16, 19, 20, 29). We speculate that seasonal respiratory viruses with an incubation period shorter than SARS-CoV-2 may have been influenced more and earlier by lockdown and distancing measures. Moreover, SARS-CoV-2 could originate interference mechanisms in order to reduce other respiratory viral infections. Yet, studies performed so far are contrasting and not conclusive (18, 21). Indeed, some authors reported a significant rate of viral coinfection with SARS-CoV-2 (30, 31). In our population the proportions of negative, positive and co-detections did not significantly differ between COVID-19 season and the previous ones, but the low rate of SARS-CoV-2 infections (only 2 out of 16 patients) does not allow solid conclusions. The virus structure could play a role too. It is likely that public health measures and NPIs have a stronger impact on enveloped viruses. In fact, the absence of an envelope might explain why Rhinovirus has represented the most frequent virus in our study-population during the last season, and why other respiratory viruses such as Adenovirus and Bocavirus were less affected by the use of face masks and social distancing. Non-enveloped viruses have a greater stability in the environment and are able to survive for extended periods outside the host (32). This makes transmission through droplets less essential for their diffusion, hence their ability to overcome NPIs.

In our study, children hospitalized for LRTIs during the COVID-19 season were older and with more comorbidities, their hospital stay was shorter and oxygen therapy was used less frequently. In addition, no patient during the 2020/2021 season needed admission to the Pediatric Intensive Care Unit, nor mechanical ventilation. These results suggest that infections during the COVID-19 season were milder, affecting predominantly children with an underlying predisposing disease, and that our findings are not influenced by an underutilization of health care (33). A possible explanation may be the change of etiology, in particular the disappearance of RSV, which is known to cause more severe LRTIs (12).

Some limitations of this study should be acknowledged. First, we report a single-center experience, although it is the main Hospital in the center of Milan, the largest city of the Lombardy, that has been the epicenter of the COVID-19 pandemic in Italy. Second, we performed a retrospective analysis, taking into account only children under 2 years of age who required hospitalizations, thus we do not have the whole picture of the prevalence of these viruses in the general population. Data refer to three winter seasons only, thus the estimation of the “typical” pre-COVID season pattern of hospitalization may be subject to a larger random variation.

However, to our knowledge, this is the first study comparing the epidemiology and the role of viruses in LRTIs in children across three winter seasons at the turn of SARS-CoV-2 spread in Italy. Although these preliminary single-center findings need confirmation from a larger surveillance, they are consistent with emerging reports from Brazil (20), Alaska (34), Australia (35), Finland (36), New Zeland (19), France (37), US (38) and Italy (39).

The long-term consequences of the different exposure to viruses in early infancy of children born in 2020 need monitoring at multiple levels, within a range covering the general health of the infant population as well as environmental micro-ecology.

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics Statement

The studies involving human participants were reviewed and approved by the institutional ethics board of IRCCS Fondazione Ca' Granda Ospedale Maggiore Policlinico, Milan. Written informed consent from the participants' legal guardian/next of kin was not required to participate in this study in accordance with the national legislation and the institutional requirements.

Author Contributions

CA and AL had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the analysis. AL, GI, CA, and PM: concept and design. AL, GI, GU, CA, and PM: drafting of the manuscript, critical revision of the manuscript for important intellectual content, and administrative, technical, or material support. GI, AL, GU, GD, PB, SS, RP, CT, SB, CA, and PM: acquisition, analysis, or interpretation of data. AV: statistical analysis. All authors contributed to the article and approved the submitted version.

Funding

This work was supported by the Italian Ministry of Health (Ricerca Corrente 2021 438/03).

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Acknowledgments

We thank Dr Bettocchi Silvia of Fondazione De Marchi, IRCCS Ca' Granda Ospedale Maggiore, Policlinico, 20122 Milan, for her valuable contribution during the data collection. Her willingness to give her time so generously is much appreciated.

References

1. Dai L, Gao GF. Viral targets for vaccines against COVID-19. Nat Rev Immunol. (2021) 21:73–82. doi: 10.1038/s41577-020-00480-0

CrossRef Full Text | Google Scholar

2. Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. (2020) 383:2603–15. doi: 10.1056/NEJMoa2034577

CrossRef Full Text | Google Scholar

3. Ramasamy MN, Minassian AM, Ewer KJ, Flaxman AL, Folegatti PM, Owens DR, et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet. (2021) 396:1979–93. doi: 10.1016/S0140-6736(20)32466-1

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Wang Z, Schmidt F, Weisblum Y, Muecksch F, Barnes CO, Finkin S, et al. mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants. Nature. (2021) 592:616–22. doi: 10.1038/s41586-021-03324-6

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Fiocchi A, Jensen-Jarolim E. SARS-COV-2, can you be over it. World Allergy Organ J. (2021) 14:100514. doi: 10.1016/j.waojou.2021.100514

CrossRef Full Text | Google Scholar

6. Civil Protection Department Chronology of Main Steps and Legal Acts Taken by the Italian Government for the Containment of the COVID-19 Epidemiological Emergency. (2020). Available online at: http://www.protezionecivile.gov.it/documents/20182/1227694/Summary+of+measures+taken+against+the+spread+of+C-19/c16459ad-4e52-4e90-90f3-c6a2b30c17eb (accessed March 12, 2020).

7. Epicentro. COVID-19 Integrated Surveillance: Key National Data. Rome: Istituto Superiore di Sanità. Available online at: https://www.epicentro.iss.it/en/coronavirus/sars-cov-2-integrated-surveillance-data#writers (accessed June 1, 2021).

8. Auger KA, Shah SS, Richardson T, Hartley D, Hall M, Warniment A, et al. Association between statewide school closure and COVID-19 incidence and mortality in the US. JAMA. (2020) 324:859–70. doi: 10.1001/jama.2020.14348

PubMed Abstract | CrossRef Full Text | Google Scholar

9. Larosa E, Djuric O, Cassinadri M, Cilloni S, Bisaccia E, Vicentini M, et al. Secondary transmission of COVID-19 in preschool and school settings in northern Italy after their reopening in September 2020: a population-based study. Euro Surveill. (2020) 25:2001911. doi: 10.2807/1560-7917.ES.2020.25.49.2001911

PubMed Abstract | CrossRef Full Text | Google Scholar

10. Milani GP, Marchisio P, Rocchi A, Bertolozzi G, Furlan L, La Vecchia A, et al. Frequency of asymptomatic carriers of SARS-CoV-2 among children and adults after school reopening. Ital J Pediatr. (2021) 47:65. doi: 10.1186/s13052-021-01016-5

PubMed Abstract | CrossRef Full Text | Google Scholar

11. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. (2020) 11:CD006207. doi: 10.1002/14651858.CD006207.pub5

PubMed Abstract | CrossRef Full Text | Google Scholar

12. Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the global burden of disease study 2016. Lancet Infect Dis. (2018) 18:1191–210. doi: 10.1016/S1473-3099(18)30310-4

PubMed Abstract | CrossRef Full Text | Google Scholar

13. Lei C, Yang L, Lou CT, Yang F, SiTou KI, Hu H, et al. Viral etiology and epidemiology of pediatric patients hospitalized for acute respiratory tract infections in Macao: a retrospective study from 2014 to 2017. BMC Infect Dis. (2021) 21:306. doi: 10.1186/s12879-021-05996-x

PubMed Abstract | CrossRef Full Text | Google Scholar

14. Althouse BM, Flasche S, Toizumi M, Nguyen HT, Vo HM, Le MN, et al. Differences in clinical severity of respiratory viral infections in hospitalized children. Sci Rep. (2021) 11:5163. doi: 10.1038/s41598-021-84423-2

PubMed Abstract | CrossRef Full Text | Google Scholar

15. Huang QS, Wood T, Jelley L, Jennings T, Jefferies S, Daniells K, et al. Impact of the COVID-19 nonpharmaceutical interventions on influenza and other respiratory viral infections in New Zealand. Nat Commun. (2021) 12:1001. doi: 10.1038/s41467-021-21157-9

PubMed Abstract | CrossRef Full Text | Google Scholar

16. Redlberger-Fritz M, Kundi M, Aberle SW, Puchhammer-Stöckl E. Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria. J Clin Virol. (2021) 137:104795. doi: 10.1016/j.jcv.2021.104795

PubMed Abstract | CrossRef Full Text | Google Scholar

17. Trenholme A, Webb R, Lawrence S, Arrol S, Taylor S, Ameratunga S, et al. COVID-19 and infant hospitalizations for seasonal respiratory virus infections, New Zealand, 2020. Emerg Infect Dis. (2021) 27:641–3. doi: 10.3201/eid2702.204041

PubMed Abstract | CrossRef Full Text | Google Scholar

18. Varela FH, Scotta MC, Polese-Bonatto M, Sartor ITS, Ferreira CF, Fernandes IR, et al. Absence of detection of RSV and influenza during the COVID-19 pandemic in a brazilian cohort: likely role of lower transmission in the community. J Glob Health. (2021) 11:05007. doi: 10.7189/jogh.11.05007

PubMed Abstract | CrossRef Full Text | Google Scholar

19. Tang JW, Bialasiewicz S, Dwyer DE, Dilcher M, Tellier R, Taylor J, et al. Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID-19 pandemic. J Med Virol. (2021) 93:4099–101. doi: 10.1002/jmv.26964

PubMed Abstract | CrossRef Full Text | Google Scholar

20. Poole S, Brendish NJ, Clark TW. SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study. J Infect. (2020) 81:966–72. doi: 10.1016/j.jinf.2020.11.010

PubMed Abstract | CrossRef Full Text | Google Scholar

21. Sullivan SG, Carlson S, Cheng AC, Chilver MB, Dwyer DE, Irwin M, et al. Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. (2020) 25:2001847. doi: 10.2807/1560-7917.ES.2020.25.47.2001847

PubMed Abstract | CrossRef Full Text | Google Scholar

22. Rapporto Influnet Epidemiologico. (2021). Available online at: https://w3.iss.it/site/RMI/influnet/pagine/rapportoInflunet.aspx (accessed June 1, 2021).

23. McAllister DA, Liu L, Shi T, Chu Y, Reed C, Burrows J, et al. Global, regional, and national estimates of pneumonia morbidity and mortality in children younger than 5 years between 2000 and 2015: a systematic analysis. Lancet Glob Health. (2019) 7:e47–57. doi: 10.1016/S2214-109X(18)30408-X

PubMed Abstract | CrossRef Full Text | Google Scholar

24. Shi T, McLean K, Campbell H, Nair H. Aetiological role of common respiratory viruses in acute lower respiratory infections in children under five years: a systematic review and meta-analysis. J Glob Health. (2015) 5:010408. doi: 10.7189/jogh.05.010408

PubMed Abstract | CrossRef Full Text | Google Scholar

25. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. (2020) 395:1973–87. doi: 10.1016/S0140-6736(20)31142-9

PubMed Abstract | CrossRef Full Text | Google Scholar

26. Koopman LP, Smit HA, Heijnen ML, Wijga A, van Strien RT, Kerkhof M, et al. Respiratory infections in infants: interaction of parental allergy, child care, and siblings– the PIAMA study. Pediatrics. (2001) 108:943–8. doi: 10.1542/peds.108.4.943

PubMed Abstract | CrossRef Full Text | Google Scholar

27. American Academy of Pediatrics. COVID-19 Guidance for Safe Schools. Available online at: https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-planning-considerations-return-to-in-person-education-in-schools (accessed June 1, 2021).

28. Leung NHL, Chu DKW, Shiu EYC, Chan KH, McDevitt JJ, Hau BJP, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. (2020) 26:676–80. doi: 10.1038/s41591-020-0843-2

PubMed Abstract | CrossRef Full Text | Google Scholar

29. Maharaj AS, Parker J, Hopkins JP, Gournis E, Bogoch II, Rader B, et al. The effect of seasonal respiratory virus transmission on syndromic surveillance for COVID-19 in Ontario, Canada. Lancet Infect Dis. (2021) 21:593–4. doi: 10.1016/S1473-3099(21)00151-1

PubMed Abstract | CrossRef Full Text | Google Scholar

30. Kim D, Quinn J, Pinsky B, Shah NH, Brown I. Rates of co-infection between SARS-CoV-2 and other respiratory pathogens. JAMA. (2020) 323:2085–6. doi: 10.1001/jama.2020.6266

PubMed Abstract | CrossRef Full Text | Google Scholar

31. Jiang S, Liu P, Xiong G, Yang Z, Wang M, Li Y, et al. Coinfection of SARS-CoV-2 and multiple respiratory pathogens in children. Clin Chem Lab Med. (2020) 58:1160–1. doi: 10.1515/cclm-2020-0434

PubMed Abstract | CrossRef Full Text | Google Scholar

32. Charlton CL, Babady E, Ginocchio CC, Hatchette TF, Jerris RC, Li Y, et al. Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections. Clin Microbiol Rev. (2019) 32:e00042–18. doi: 10.1128/CMR.00042-18

PubMed Abstract | CrossRef Full Text | Google Scholar

33. Lucero AD, Lee A, Hyun J, Lee C, Kahwaji C, Miller G, et al. Underutilization of the emergency department during the COVID-19 pandemic. West J Emerg Med. (2020) 21:15–23. doi: 10.5811/westjem.2020.8.48632

PubMed Abstract | CrossRef Full Text | Google Scholar

34. Nolen LD, Seeman S, Bruden D, Klejka J, Desnoyers C, Tiesinga J, et al. Impact of social distancing and travel restrictions on non-COVID-19 respiratory hospital admissions in young children in rural alaska. Clin Infect Dis. 72:2196–8. doi: 10.1093/cid/ciaa1328

PubMed Abstract | CrossRef Full Text | Google Scholar

35. Britton PN, Hu N, Saravanos G, Shrapnel J, Davis J, Snelling T, et al. COVID-19 public health measures and respiratory syncytial virus. Lancet Child Adolesc Health. (2020) 4:e42–3. doi: 10.1016/S2352-4642(20)30307-2

PubMed Abstract | CrossRef Full Text | Google Scholar

36. Kuitunen I, Artama M, Mäkelä L, Backman K, Heiskanen-Kosma T, Renko M. Effect of social distancing due to the COVID-19 pandemic on the incidence of viral respiratory tract infections in children in finland during early 2020. Pediatr Infect Dis J. (2020) 39:e423–7. doi: 10.1097/INF.0000000000002845

PubMed Abstract | CrossRef Full Text | Google Scholar

37. Rambaud J, Dauger S, Morin L, Bergounioux J, Leger PL, Carbajal R, et al. Bronchiolitis admissions to intensive care during COVID. Pediatrics. 147:e2021050103. doi: 10.1542/peds.2021-050103

PubMed Abstract | CrossRef Full Text | Google Scholar

38. Gill PJ, Mahant S, Hall M, Berry JG. Reasons for admissions to US children's hospitals during the COVID-19 pandemic. JAMA. (2021) 325:1676–9. doi: 10.1001/jama.2021.4382

PubMed Abstract | CrossRef Full Text | Google Scholar

39. Amaddeo A, Cason C, Cozzi G, Ronfani L, Comar M. Social distancing measures for COVID-19 are changing winter season. Arch Dis Child. doi: 10.1136/archdischild-2021-322004. [Epub ahead of print].

PubMed Abstract | CrossRef Full Text | Google Scholar